These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 10588521

  • 1. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
    Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM.
    BMJ; 1994 Dec 17; 309(6969):1608-12. PubMed ID: 7819935
    [Abstract] [Full Text] [Related]

  • 10. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Vilarrasa N, Soler J, Montanya E.
    Acta Diabetol; 2005 Jun 17; 42(2):87-94. PubMed ID: 15944842
    [Abstract] [Full Text] [Related]

  • 11. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
    Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M, International Diabetic Nephopathy Study Group.
    Diabetes; 2005 Jul 17; 54(7):2164-71. PubMed ID: 15983218
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.
    Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N.
    Diabetologia; 2004 Jun 17; 47(6):1020-8. PubMed ID: 15170497
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG, Semplicini A, Morocutti A, Maioli M, Cipollina MR, Barzon I, Palaro C, Brocco E, Trevisan M, Fioretto P, Crepaldi G, Nosadini R.
    Diabetologia; 1997 Jun 17; 40(6):654-61. PubMed ID: 9222644
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Severity of glomerulopathy predicts long-term urinary albumin excretion rate in patients with type 1 diabetes and microalbuminuria.
    Bangstad HJ, Osterby R, Hartmann A, Berg TJ, Hanssen KF.
    Diabetes Care; 1999 Feb 17; 22(2):314-9. PubMed ID: 10333951
    [Abstract] [Full Text] [Related]

  • 19. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212
    [Abstract] [Full Text] [Related]

  • 20. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan 21; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.